Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV06/11/2024 | Chg.+30.7302 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 2,293.1201EUR | +1.36% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
| 2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
| 2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
| 2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
| 2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
| 2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
| 2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
| 2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
| 2024 | 1.22 | 1.20 | -0.07 | -6.27 | 4.01 | 5.19 | 6.29 | 1.46 | -2.45 | -1.77 | 3.91 | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 16.10% | 15.80% | 16.95% | 20.07% | 22.53% |
| Ratio de Sharpe | 0.75 | 1.51 | 1.55 | -0.02 | 0.22 |
| Le meilleur mois | +13.23% | +6.29% | +13.23% | +13.23% | +13.23% |
| Le plus défavorable mois | -6.27% | -2.45% | -6.27% | -10.88% | -10.88% |
| Perte maximale | -11.21% | -7.10% | -11.21% | -26.82% | -32.04% |
| Surperformance | +1.76% | - | +1.73% | -5.87% | +3.46% |
Toutes les cotations dans EUR
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,293.1201 | +29.35% | +8.04% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,507.1399 | +31.87% | +25.44% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,757.7300 | +26.71% | +21.77% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,081.5000 | +33.49% | +20.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 249.1500 | +31.99% | +25.67% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 396.8700 | +28.01% | +25.83% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 369.1900 | +33.23% | +29.07% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 222.3600 | +27.41% | +6.09% | |
| Candriam Equities L Biotechnolog... | reinvestment | 166.1700 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 672.1200 | +31.51% | +15.23% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,364.3901 | +31.66% | +17.07% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,309.8101 | +31.93% | +16.58% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 219.9200 | +29.59% | +8.41% | |
| Candriam Equities L Biotech.R US... | reinvestment | 303.4400 | +32.81% | +20.42% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 230.2100 | +30.68% | +11.12% | |
| Candriam Equities L Biotechnolog... | reinvestment | 951.4000 | +31.62% | +17.41% | |
| Candriam Equities L Biotechnolog... | paying dividend | 862.9700 | +31.94% | +16.52% |
Performance
| CAD | +12.73% | ||
|---|---|---|---|
| 6 Mois | +12.74% | ||
| 1 An | +29.35% | ||
| 3 Ans | +8.04% | ||
| 5 Ans | +46.49% | ||
| 10 ans | - | ||
| Depuis le début | +52.87% | ||
| Année | |||
| 2023 | +4.95% | ||
| 2022 | -5.50% | ||
| 2021 | -2.71% | ||
| 2020 | +18.93% | ||
| 2019 | +30.43% | ||
| 2018 | -13.02% | ||
| 2017 | +24.87% | ||
| 2016 | -19.97% | ||
